KKR completes take-private buyout of Envision

KKR has closed its take-private acquisition of Envision Healthcare Corp for $46 per share. As a result of the closing, Envision will stop trading on the New York Stock Exchange. Based in Nashville, Envision is a provider of physician-led services and post-acute care and ambulatory surgery services. PRESS RELEASE NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) today announced the completion of the previously announced acquisition of Envision by global investment firm KKR. As a result of the completion of the merger, Envision has become a wholly owned subsidiary of funds affiliated with KKR, and Envision stockholders will receive an amount in cash equal to $46.00 per share of Envision common stock. As a result of the completion of the merger, shares of Envision’s common stock ceased trading on the NYSE prior to the opening of the NYSE today. About Envision Healthcare Corporation
Envision Healthcare
Continue reading "KKR completes take-private buyout of Envision"

PE-backed NavaDerm appoints executive team

NavaDerm Partners, a Northeast-based regional dermatology platform and portfolio company of BelHealth Investments Partners LLC, has named Alejandro Fernandez as CEO. Also, NavaDerm has appointed Edward Conway as chief financial officer and Kimberly Campbell as executive vice president of business development and recruiting. PRESS RELEASE New York, New York – July 20, 2018 – NavaDerm Partners, LLC (“NavaDerm” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, announced the appointment of NavaDerm’s executive management team. NavaDerm named Alejandro Fernandez as Chief Executive Officer. Mr. Fernandez has over 25 years of experience leading multi-site physician practice operations. Mr. Fernandez was most recently the Chief Executive Officer for Gastro Health, a practice management company that specializes in owning and operating gastroenterology practices and ambulatory surgical centers. In this role, Mr. Fernandez oversaw a number of acquisitions, de novo practice formations, and
Continue reading "PE-backed NavaDerm appoints executive team"

KKR to buy Envision Healthcare for $9.9 bln

KKR agreed to buy Envision Healthcare for $9.9 billion, including debt. KKR is buying all of Envision’s outstanding stock for $46 a share. The $9.9 billion deal means Envision is selling for a 10.9x trailing 12 months Adjusted EBITDA. Envision is a U.S. physician services provider. PRESS RELEASE NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) today announced it has entered into a definitive agreement to be acquired by global investment firm KKR in an all-cash transaction for approximately $9.9 billion, including the assumption or repayment of debt. Under the terms of the agreement, which has been unanimously approved by Envision’s Board of Directors (the “Board”), KKR will acquire all of the outstanding shares of Envision’s common stock for $46.00 per share in cash, representing a 32% premium to Envision’s volume-weighted average share price (VWAP) from November 1, 2017, the
Continue reading "KKR to buy Envision Healthcare for $9.9 bln"

Revelstoke Capital adds operating partners

Revelstoke Capital Partners said Sept. 19 that Steve Geringer and Greg Steil have joined as Operating Partners. Geringer is the Chairman of AmSurg Corp while Steil is the Founder of ATI Physical Therapy. PRESS RELEASE Denver, CO (September 19, 2016) – Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, today announced it has expanded its team with two new operating partners: Steve Geringer, Chairman of AmSurg Corp. (Nasdaq: AMSG), and Greg Steil, Founder of ATI Physical Therapy Holdings, Inc. (“ATI Physical Therapy”). Mr. Geringer and Mr. Steil will also join the board of directors of Fast Pace Urgent Care (“Fast Pace”), Revelstoke’s newest portfolio company. “I’ve worked closely with Steve and Greg for many years. Their combined knowledge in clinic-based healthcare operations and healthcare services is unmatched,” said Simon Bachleda, Managing Partner and Co-Founder of Revelstoke, and Chairman of the Board of Fast Pace. “Both are successful entrepreneurs, experienced
Continue reading "Revelstoke Capital adds operating partners"

Envision Healthcare Holdings’ (EVHC) CEO William Sanger on Q2 2014 Results – Earnings Call Transcript

    <p>Start Time: 17:00</p> <p>End Time: 18:01</p> <p>Envision Healthcare Holdings, Inc. (NYSE:<a href='http://seekingalpha.com/symbol/evhc' title='Envision Healthcare Holdings'>EVHC</a>)</p> <p>Q2 2014 Earnings Conference Call</p> <p>August 06, 2014, 17:00 PM ET</p> <p>

Craig Wilson - SVP and General Counsel William A. Sanger - CEO Randel G. Owen - EVP and CFO Analysts Andrew Schenker - Morgan Stanley Ryan Daniels - William Blair Ralph Jacoby - Credit Suisse Darren Lehrich - Deutsche Bank Frank Morgan - RBC Capital Markets Brian Tanquilut - Jefferies A.J. Rice - UBS Kevin Fischbeck - Bank of America Merrill Lynch Gary Taylor - Citigroup Josh Raskin - Barclays Capital Matthew Gilmore - Robert W. Baird Presentation Operator Welcome to the Envision Healthcare Holdings Second Quarter 2014 Conference Call. At this time, all participants are in listen-only mode. (Operator Instructions). Today’s conference is being recorded. If you have any objections, you may disconnect at this time. Now I will turn the call over to Craig Wilson,
                                                                                                                                                                                                                                                                                   <br/><a href='http://seekingalpha.com/article/2392575-envision-healthcare-holdings-evhc-ceo-william-sanger-on-q2-2014-results-earnings-call-transcript?source=feed'>Complete Story &raquo;</a>